Loving Addyi: How Americans and Germans celebrate Viagra for women

Content Fleet 28/08/2015
Loving Addyi: How Americans and Germans celebrate Viagra for women

Addyi boosts the female libido. This promise has generated a lot of excitement in the USA and Germany. The Content Fleet Big Data Analysis gives us a picture of how the passion pill has been received by the international online journalists‘ community.

Viagra for Women: the Peaks in Online Reporting

It has taken five years for „Viagra for women“ to be approved as a drug in the USA. A long period of excited anticipation came to a successful climax this summer when on June 4th experts from the FDA (American Food and Drug Administration) issued a recommendation for the passion pill. Finally on August 18th Pink Viagra, under the name of Addyi trading with the trade name Flibanserin, was approved for the US market.

The peaks in excitement over the Addyi Affair are reflected in global online reporting. Over the last three months there have been almost 1,100 reports on the pharmaceutical product with the topic climaxing, so to say, first on the day approval was recommended, and then quite significantly on the day it was actually approved.

 

Viagra_1_Number of Publications
Number of publications with keywords Addyi and/or Flibanserin. Source: Content Fleet [27.05.2015-27.08.2015] (© 2015 Gast)
 

 

Female Libido: Who’s Interested?

Without question the approval of Addyi has been of great interest to the international online journalists‘ community. However, it has not been the same overall. There was significantly more reporting on the passion pill in the USA (346 publications) and in Germany (264 publications), followed by the UK, Austria, France, Switzerland, South Korea, India and Canada.

Viagra_2_Publication Countries
Countries with the most publications with keywords Addyi and/or Flibanserin. Source: Content Fleet [27.05.2015-27.08.2015] (© 2015 Gast)
 

The American-German domination is also reflected in related topics. The 10 most frequently occurring words used in combination with Addyi and/or Flibanserin, originate in Angloamerican and German speaking territories.

 

Viagra_3_Related Topis
Keywords most frequently used in combination with keywords Addyi and/or Flibanserin. Source: Content Fleet [27.05.2015-27.08.2015] (© 2015 Gast)
 

Conspicuously absent: In countries where Islam is the state religion the topic of Viagra for women is mostly not mentioned. Only in the UAE (United Arabic Emirates) and Malaysia did they report on Addyi.

 

Viagra_4_Global Article Publications
View of global publication of articles in the context of keywords Addyi and/or Flibanserin. Source: Content Fleet [27.05.2015-27.08.2015] (© 2015 Gast)
 

Desire for More Passion?

The response by users to the approval of Viagra for Women has been largely positive. Looking at the top ten most viral articles and posts on Facebook and Twitter over the the last three months shows that articles that are neutral to positive generate the most engagement.

 

Viagra_5_Most Viral Articles
Most successful publications in the context of keywords Addyi and/or Flibanserin. Source: Content Fleet [27.05.2015-27.08.2015] (© 2015 Gast)
 

Viagra_6_Most Viral Facebook Posts
The most popular Facebook posts in the context of keywords Addyi and/or Flibanserin. Source: Content Fleet [27.05.2015-27.08.2015] (© 2015 Gast)
 

Viagra_7_Most Viral Tweets
The most popular Twitter posts in the context of keywords Addyi and/or Flibanserin. Source: Content Fleet [27.05.2015-27.08.2015] (© 2015 Gast)
 

The media hype started fading one week after Addyi was approved. Significantly less articles are being published – however, with the content focus on different issues. Amongst the top ten most viral articles of the past week, two focus on critical aspects of the drug: "Female viagra is another example of society trying to make women sexually "normal" on men'sterms" on newstatesman.com and "The real problem with 'pink viagra'" on latimes.com. Both argue that pathologising weak libido in women causes more harm than good.

 

Viagra_8
The most popular Facebook posts in the context of keywords Addyi and/or Flibanserin. Source: Content Fleet [20.08.2015-27.08.2015]
 

Conclusion

Viagra for women generated high levels of online excitement, which were, however, short-lived. The peaks are closely connected to two events , namely the recommendation for approval on June 4th and the approval itself on August 18th. For two to three days following these events there was excessive reporting on Addyi with interest fading after that. As time goes by the nature of the content has changed, and ranges from neutral to positive short reports to critical analyses of the social and cultural aspects of female libido.

Along with the US Americans, who were directly affected by the approval, the Germans have also shown a great deal of interest in the topic. One reason may be that the compound was originally developed by the German company, Boehringer Ingelheim before it was sold onto the US company, Sprout Pharmaceuticals.

North America and Europe appear to be the territories with the most promising market potential for a drug that boosts female libido. In Asia there seems to be increasing interest in South Korea, and India. However, Viagra for women is a sensitive topic in countries where Islam is the state religion with the exception of the UAE (United Arabic Emirates) and Malaysia.

More articles